Rigel Pharmaceuticals (RIGL) News Today $26.83 -1.35 (-4.79%) Closing price 04:00 PM EasternExtended Trading$26.89 +0.06 (+0.22%) As of 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RIGL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period How Rigel Pharmaceuticals’ R289 Trial Progress and FDA Designations Will Impact RIGL InvestorsOctober 12 at 1:39 PM | finance.yahoo.comRigel Pharmaceuticals (NASDAQ:RIGL) Receives "Hold (C+)" Rating from Weiss RatingsOctober 10 at 5:37 AM | marketbeat.comRigel Pharmaceuticals, Inc.: Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDSOctober 8, 2025 | finanznachrichten.deRigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Down 4% - What's Next?October 8, 2025 | marketbeat.comRigel Pharmaceuticals' (RIGL) "Buy" Rating Reiterated at HC WainwrightOctober 8, 2025 | marketbeat.comRigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDSOctober 8, 2025 | prnewswire.comRigel Pharmaceuticals (NASDAQ:RIGL) Downgraded to "Hold" Rating by Zacks ResearchOctober 8, 2025 | marketbeat.comAnalysts Set Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) PT at $38.20October 8, 2025 | americanbankingnews.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Recommendation of "Hold" from AnalystsOctober 5, 2025 | marketbeat.comRigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)October 3, 2025 | prnewswire.comRigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Crosses Above Two Hundred Day Moving Average - Here's What HappenedOctober 3, 2025 | marketbeat.comVoya Strengthens Position in Rigel Pharmaceuticals, Inc. (RIGL)September 29, 2025 | insidermonkey.comRigel Pharmaceuticals: Strong Growth Trajectory And Commercial ExpansionSeptember 25, 2025 | seekingalpha.comAssenagon Asset Management S.A. Reduces Position in Rigel Pharmaceuticals, Inc. $RIGLSeptember 25, 2025 | marketbeat.comRigel Pharmaceuticals (NASDAQ:RIGL) Shares Down 4.1% - Here's WhySeptember 24, 2025 | marketbeat.comVoya Investment Management LLC Sells 22,411 Shares of Rigel Pharmaceuticals, Inc. $RIGLSeptember 23, 2025 | marketbeat.comStrs Ohio Takes Position in Rigel Pharmaceuticals, Inc. $RIGLSeptember 23, 2025 | marketbeat.comGoldman Sachs Group Inc. Sells 107,461 Shares of Rigel Pharmaceuticals, Inc. $RIGLSeptember 22, 2025 | marketbeat.comLisa Rojkjaer Enhances Portfolio With Rigel Pharmaceuticals Stock Options: $90K AcquiredSeptember 19, 2025 | benzinga.comRaymond Furey At Rigel Pharmaceuticals Secures Company Stock Options: $90K AcquiredSeptember 18, 2025 | benzinga.comCEO At Rigel Pharmaceuticals Acquires Company Stock Options Worth $388KSeptember 18, 2025 | benzinga.comRigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Down 4.9% - Should You Sell?September 17, 2025 | marketbeat.comWhat Does Wall Street Think About Rigel Pharmaceuticals (RIGL)?September 17, 2025 | insidermonkey.comAcadian Asset Management LLC Grows Stock Position in Rigel Pharmaceuticals, Inc. $RIGLSeptember 15, 2025 | marketbeat.comDynamic Technology Lab Private Ltd Acquires Shares of 27,117 Rigel Pharmaceuticals, Inc. $RIGLSeptember 13, 2025 | marketbeat.comRigel Pharmaceuticals (NASDAQ:RIGL) Shares Down 6.1% - Here's What HappenedSeptember 11, 2025 | marketbeat.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Sees Significant Drop in Short InterestSeptember 11, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Grows Stock Holdings in Rigel Pharmaceuticals, Inc. $RIGLSeptember 11, 2025 | marketbeat.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Average Recommendation of "Hold" by AnalystsSeptember 11, 2025 | marketbeat.comA Look At The Intrinsic Value Of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)September 9, 2025 | uk.finance.yahoo.comTrexquant Investment LP Lowers Stock Holdings in Rigel Pharmaceuticals, Inc. $RIGLSeptember 9, 2025 | marketbeat.comDo Options Traders Know Something About RIGL Stock We Don't?September 6, 2025 | msn.comRafferty Asset Management LLC Makes New Investment in Rigel Pharmaceuticals, Inc. $RIGLSeptember 5, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Sells 11,070 Shares of Rigel Pharmaceuticals, Inc. $RIGLSeptember 3, 2025 | marketbeat.comArmistice Capital LLC Has $27.27 Million Stock Holdings in Rigel Pharmaceuticals, Inc. $RIGLSeptember 2, 2025 | marketbeat.comRigel Pharmaceuticals, Inc. $RIGL Shares Bought by Wellington Management Group LLPSeptember 2, 2025 | marketbeat.com115,218 Shares in Rigel Pharmaceuticals, Inc. $RIGL Bought by Nuveen LLCSeptember 1, 2025 | marketbeat.comInvesco Ltd. Purchases Shares of 134,072 Rigel Pharmaceuticals, Inc. $RIGLSeptember 1, 2025 | marketbeat.comVanguard Group Inc. Has $18.50 Million Stake in Rigel Pharmaceuticals, Inc. $RIGLSeptember 1, 2025 | marketbeat.comRigel to Participate in Upcoming September Investor ConferencesAugust 26, 2025 | prnewswire.comThis ‘Darling’ Pharma Stock Is Hitting New Highs, But the Momentum Could Run Out SoonAugust 25, 2025 | finance.yahoo.comThis ‘Darling’ Pharma Stock Is Hitting New HighsAugust 25, 2025 | barchart.comRigel Pharmaceuticals (NASDAQ:RIGL) Reaches New 1-Year High - What's Next?August 21, 2025 | marketbeat.comRigel Pharmaceuticals (NASDAQ:RIGL) Sees Strong Trading Volume - Should You Buy?August 20, 2025 | marketbeat.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Recommendation of "Hold" from BrokeragesAugust 17, 2025 | marketbeat.comRigel Pharmaceuticals (NASDAQ:RIGL) Trading Up 3.3% - Should You Buy?August 16, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Increases Stock Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)August 16, 2025 | marketbeat.comRigel Pharmaceuticals (NASDAQ:RIGL) Sets New 12-Month High - Time to Buy?August 14, 2025 | marketbeat.comRigel Pharmaceuticals: Q2 Earnings Fuel A Potential BreakoutAugust 13, 2025 | seekingalpha.comRigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are Of Questionable QualityAugust 13, 2025 | finance.yahoo.com Get Rigel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RIGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RIGL Media Mentions By Week RIGL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RIGL News Sentiment▼0.260.77▲Average Medical News Sentiment RIGL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RIGL Articles This Week▼125▲RIGL Articles Average Week Get the Latest News and Ratings for RIGL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Rigel Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies MannKind News Celldex Therapeutics News Novavax News BioCryst Pharmaceuticals News OPKO Health News Dynavax Technologies News Innoviva News Zenas BioPharma News Geron News Myriad Genetics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RIGL) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rigel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rigel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
